Press Releases

February 9, 2022 Lupin Signs Distribution Agreement with Medis for Orphan Drug NaMuscla®

February 8, 2022 Lupin Receives Approval from U.S. FDA for Arformoterol Tartrate Inhalation Solution15 mcg (base)/2 ml

February 3, 2022 Lupin Quarter 3 FY2022 Results

February 1, 2022 Lupin and Axantia Enter into a License, Supply and Technology Sharing Agreement for Pegfilgrastim in the Middle East and North Africa

January 27, 2022 Lupin Signs Promotional Agreement with Exeltis on SOLOSEC® expanding access for Adult Women Suffering with Bacterial Vaginosis and Adults with Trichomoniasis

January 19, 2022 Lupin Signs First Partnership Agreement with Foncoo for China

January 7, 2022 Lupin launches Molnupiravir under the brand name Molnulup for the treatment of COVID-19 in adults in India

December 25, 2021 Lupin Receives Approval from U.S. FDA for Sevelamer Carbonate for Oral Suspension

December 24, 2021 Lupin Receives Tentative Approval from U.S. FDA for Azilsartan Medoxomil Tablets